AI-assisted Migraine Education: Efficacy, Safety and Patients' Acceptance
Migraine affects 1 in 7 people globally, significantly impacting quality of life and economic productivity. Despite its prevalence, limited awareness leads to misdiagnosis, inadequate treatment, and stigmatization. AI can enhance migraine management through improved diagnosis, prediction, and personalized education. The primary objective of this study is to determine if adding AI-assisted migraine education to standard education improves patients' understanding of their condition more effectively.
• aged between 18 and 65 years at the time of signing the informed consent
• Newly diagnosis of migraine, confirmed through the medical chart
• The participant must be capable of giving signed informed consent
• Access to a laptop, computer, smartphone, or tablet